Navitoclax-piperazine l 3 (>90%) blocking dopamine-induced inhibition of Ca2+

blocking dopamine-induced inhibition of Ca2+ currents in transfected GH4C1 pituitary cells

Compound list:  (+)-JQ1

SRX3207 potently inhibited Syk and PI3K signaling and augmented the anti-tumor immune response in lung carcinoma tumor model with no toxicity

PubMed Central PMCID: PMC4918824

Navitoclax-piperazine l 3 (>90%) blocking dopamine-induced inhibition of Ca2+Navitoclax piperazine (ABT 263 piperazine) is a B cell lymphoma extra large (BCL XL) inhibitor. Navitoclax piperazine and a VHL ligand for the E3 ubiquitin ligase can be used in the synthesis of PROTAC DT2216 (HY 130604). Product information CAS Number: 2143096 93 7 Molecular Weight: 973. 63 Formula: C47H56ClF3N6O5S3 Chemical Name: 4 (4 {[2 (4 chlorophenyl) 5,5 dimethylcyclohex 1 en 1 yl]methyl}piperazin 1 yl) N (4 {[(2R) 1 (phenylsulfanyl) 4